We’re launching a new capital increase for 2022

We aim to finance Phase III clinical trials for brain tumor treatment.

For more information about this investment opportunity

email inversores@laminarpharma.com.

You can also find the information about the last

Crowdfunding for Laminar Pharma at Capital Cell

finished successfully in July 2022.

Company News

Scientific publications